Persephone Biosciences
Stephanie Culler's work experience includes being a Co-Founder and CEO at Persephone Biosciences since July 2017. Prior to that, they worked at Genomatica from September 2010 to June 2017, starting as a Sr. Research Scientist and later becoming a Sr. Research Scientist II. Stephanie also worked as a HHMI Postdoctoral Scholar at the California Institute of Technology from September 2009 to August 2010, where they focused on developmental dynamics during the neural differentiation of embryonic stem cells. Stephanie was a Graduate Student in Chemical Engineering at the California Institute of Technology from September 2003 to May 2009, where they developed high-throughput cell-based screening platforms. Before that, Stephanie worked as an Undergraduate Researcher in Chemical Engineering at UCSD from September 2001 to September 2003, analyzing amino acid residue usage in antibodies. Stephanie also worked as an Undergraduate Researcher at the UCSD Medical Center, Stein Institute for Research on Aging from June 2002 to June 2003, studying oxidative stress in age-related voiding dysfunction. Stephanie began their undergraduate research experience at the California Institute of Technology from June 2001 to September 2001, focusing on rheological properties of polymerizable macromers.
Stephanie Culler started their education journey in 1999 at UC San Diego, where they pursued a Bachelor of Science degree in Chemical Engineering. Stephanie completed their undergraduate studies in 2003. Following this, they joined Caltech and pursued a PhD in Chemical Engineering, which they successfully completed in 2009. In 2018, Stephanie Culler participated in the W18 program at Y Combinator, but it is unclear if this program provided a specific degree or field of study. The exact start and end years for this program are not provided. Stephanie Culler also participated in the W2018 program at Y Combinator, but again, the specific degree or field of study is not specified, and the start and end years are unknown.
This person is not in any teams
Persephone Biosciences
1 followers
Persephone Biosciences develops healthcare technology designed to focus on microbial therapeutics for immuno-oncology applications. The company's technology uses artificial intelligence and omics techniques on multiple cancer patient gut microbiome and blood samples to identify microbes needed for normal immune function for population-scalepatient data analytics, enabling lab researchers to design microbial drugs that prevent and fight cancer.Persephone Biosciences was founded in 2017 and is based in San Diego, California.